Evidence map›Paper›PMID 37600801›Full record

ArticleFrontiers in immunology2023

Deletion of the non-adjacent genes

Vu Thuy Khanh Le-Trilling, Fabienne Maaßen, Benjamin Katschinski, Hartmut Hengel, Mirko Trilling

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Human cytomegalovirus and neonatal infection.Current research in microbial sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Vu Thuy Khanh Le-TrillingInstitute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Fabienne MaaßenInstitute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Benjamin KatschinskiInstitute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Hartmut HengelInstitute of Virology, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Mirko TrillingInstitute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
University of Duisburg-Essen · DEUniversity of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human cytomegalovirus (HCMV) is a prototypical β-herpesvirus which frequently causes morbidity and mortality in individuals with immature, suppressed, or senescent immunity. HCMV is sensed by various pattern recognition receptors, leading to the secretion of pro-inflammatory cytokines including tumor necrosis factor alpha (TNFα). TNFα binds to two distinct trimeric receptors: TNF receptor (TNFR) 1 and TNFR2, which differ in regard to their expression profiles, affinities for soluble and membrane-bound TNFα, and down-stream signaling pathways. While both TNF receptors engage NFκB signaling, only the nearly ubiquitously expressed TNFR1 exhibits a death domain that mediates TRADD/FADD-dependent caspase activation. Under steady-state conditions, TNFR2 expression is mainly restricted to immune cells where it predominantly submits pro-survival, proliferation-stimulating, and immune-regulatory signals. Based on the observation that HCMV-infected cells show enhanced binding of TNFα, we explored the interplay between HCMV and TNFR2. As expected, uninfected fibroblasts did not show detectable levels of TNFR2 on the surface. Intriguingly, however, HCMV infection increased TNFR2 surface levels of fibroblasts. Using HCMV variants and BACmid-derived clones either harboring or lacking the UL

Indexed as

CytomegalovirusReceptors, Tumor Necrosis Factor, Type IIViral Fusion ProteinsHumansTranscriptional ActivationTumor Necrosis Factor-alphaUp-RegulationReceptors, Tumor Necrosis Factor, Type IITNFRSF1B protein, humanTumor Necrosis Factor-alphaUL148 protein, human cytomegalovirusViral Fusion Proteinshuman cytomegalovirus (hcmv)TACE/ADAM17TNF receptor 1 (TNFR1)TNF receptor 2 (TNFR2)tumor necrosis factor alpha (TNFα)UL148UL148DULb’

Identifiers

PMID37600801
PMCPMC10437809
OpenAlexW4385516350

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.